James H Mackaness has sold SLNO and made no open-market buys since Nov 2023
CFO at Soleno Therapeutics, Inc.
SEC CIK 0001422484 · Filings on SEC.gov ↗
$0Bought
$3.8MSold
NoneLast buy
Every filing
8 filings since Nov 2023, newest first
SLNOSell
Soleno Therapeutics Inc
CFO
$399K−6.0%Oct 3
SLNOSell
Soleno Therapeutics Inc
CFO
$642K−10.0%Aug 30
SLNOSell
Soleno Therapeutics Inc
CFO
$683K−10.0%Aug 7
SLNOSell
Soleno Therapeutics Inc
CFO
$299K−11.0%Jul 3
SLNOSell
Soleno Therapeutics Inc
CFO
$214K−8.0%Apr 3
SLNOSell
Soleno Therapeutics Inc
CFO
$1.2M−73.0%Dec 13
SLNOSell
Soleno Therapeutics Inc
CFO
$120K−16.0%Dec 4
SLNOSell
Soleno Therapeutics Inc
CFO
$222K−24.0%Nov 30
Filings come from SEC EDGAR. Not investment advice.